{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T19:22:37Z","timestamp":1793992957458,"version":"4.8.0"},"reference-count":37,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,7,18]],"date-time":"2025-07-18T00:00:00Z","timestamp":1752796800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100018556","name":"Science and Technology Program of Suzhou","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100018556","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Diffuse large B-cell lymphoma (DLBCL) is a common subtype of Richter transformation (RT) in chronic lymphocytic leukaemia (CLL), accounting for 90\u201395% of all transformation cases. However, RT with isolated cerebral involvement is rare. Herein, we report the case of a 67-year-old man with DLBCL that transformed from CLL during obinutuzumab treatment. This patient developed RT with only central nervous system (CNS) involvement and no systemic features. After undergoing single-agent treatment with the CD20\u00d7CD3 bispecific antibody glofitamab, the patient regained consciousness and improved clinically. Although only one successful case has been presented, glofitamab may be considered a promising therapeutic option for patients with RT and isolated CNS involvement.<\/jats:p>","DOI":"10.3389\/fimmu.2025.1635589","type":"journal-article","created":{"date-parts":[[2025,7,18]],"date-time":"2025-07-18T04:10:26Z","timestamp":1752811826000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":5,"title":["Glofitamab treatment of Richter transformation with isolated central nervous system involvement: a case report"],"prefix":"10.3389","volume":"16","author":[{"given":"Kang","family":"Lu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaohui","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weicheng","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liying","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuemei","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bingzong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,7,18]]},"reference":[{"key":"B1","volume-title":"WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues, 4th","author":"Swerdlow","year":"2017"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.3892\/mco.2016.727","article-title":"Hodgkin\u2019s lymphoma as a rare variant of Richter\u2019s transformation in chronic lymphocytic leukemia: A case report and review of the literature","volume":"4","author":"Janjetovic","year":"2016","journal-title":"Mol Clin Oncol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13205141","article-title":"Richter transformation in chronic lymphocytic leukemia: update in the era of novel agents","volume":"13","author":"Tadmor","year":"2021","journal-title":"Cancers"},{"key":"B4","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1038\/s41467-022-34642-6","article-title":"Molecular characterization of Richter syndrome identifies de novo diffuse large B-cell lymphomas with poor prognosis","volume":"14","author":"Bros\u00e9us","year":"2023","journal-title":"Nat Commun"},{"key":"B5","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1007\/s11864-018-0555-8","article-title":"Extranodal diffuse large B cell lymphoma: molecular features, prognosis, and risk of central nervous system recurrence","volume":"19","author":"Ollila","year":"2018","journal-title":"Curr Treat Options Oncol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1007\/s00277-021-04603-y","article-title":"Outcomes of Richter\u2019s transformation of chronic lymphocytic leukemia\/small lymphocytic lymphoma (CLL\/SLL): an analysis of the SEER database","volume":"100","author":"Elnair","year":"2021","journal-title":"Ann Hematol"},{"key":"B7","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1038\/s41572-023-00439-0","article-title":"Primary central nervous system lymphoma","volume":"9","author":"Ferreri","year":"2023","journal-title":"Nat Rev Dis Primers"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2022-157544","article-title":"Glofitamab monotherapy demonstrates high complete response rates and manageable safety in Chinese patients with relapsed or refractory diffuse large B-cell lymphoma and \u22652 prior therapies","volume":"140","author":"Song","year":"2022","journal-title":"Blood"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2206913","article-title":"Glofitamab for relapsed or refractory diffuse large B-cell lymphoma","volume":"387","author":"Dickinson","year":"2022","journal-title":"New Engl J Med"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2024024168","article-title":"Glofitamab stimulates immune cell infiltration of CNS tumors and induces clinical responses in secondary CNS lymphoma","volume":"144","author":"Godfrey","year":"2024","journal-title":"Blood"},{"key":"B11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/10428194.2025.2484365","article-title":"Glofitamab induces deep and rapid response in relapsed primary central nervous system lymphoma","author":"Wang","year":"2025","journal-title":"Leuk Lymphoma"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1038\/s41375-018-0320-9","article-title":"Dose-adjusted EPOCH plus rituximab improves the clinical outcome of young patients affected by double expressor diffuse large B-cell lymphoma","volume":"33","author":"Dodero","year":"2019","journal-title":"Leukemia"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20131448","article-title":"Genetic lesions associated with chronic lymphocytic leukemia transformation to Richter syndrome","volume":"210","author":"Fabbri","year":"2013","journal-title":"J Exp Med"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1007\/s40265-023-01894-5","article-title":"Glofitamab: first approval","volume":"83","author":"Shirley","year":"2023","journal-title":"Drugs"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(24)01774-4","article-title":"Glofitamab plus gemcitabine and oxaliplatin (GemOx) versus rituximab-GemOx for relapsed or refractory diffuse large B-cell lymphoma (STARGLO): a global phase 3, randomised, open-label trial","volume":"404","author":"Abramson","year":"2024","journal-title":"Lancet (London England)"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2002-06-1636","article-title":"Rituximab therapy for CNS lymphomas: targeting the leptomeningeal compartment","volume":"101","author":"Rubenstein","year":"2003","journal-title":"Blood"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1158\/1535-7163.MCT-12-1182","article-title":"Preclinical activity of the type II CD20 antibody GA101 (obinutuzumab) compared with rituximab and ofatumumab in vitro and in xenograft models","volume":"12","author":"Herter","year":"2013","journal-title":"Mol Cancer Ther"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1093\/ajcp\/89.2.254","article-title":"Central nervous system involvement in a patient with chronic lymphocytic leukemia and non-Hodgkin's lymphoma (Richter's syndrome), with concordant cell surface immunoglobulin isotypic and immunophenotypic markers","volume":"89","author":"Lane","year":"1988","journal-title":"Am J Clin Pathol"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19890915)64:6<1296::aid-cncr2820640621>3.0.co;2-e","article-title":"Primary central nervous system lymphoma as a variant of Richter's syndrome in two patients with chronic lymphocytic leukemia","volume":"64","author":"O'Neill","year":"1989","journal-title":"Cancer"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1093\/ajcp\/93.1.117","article-title":"Richter's syndrome presenting as primary central nervous system lymphoma. Transformation of an identical clone","volume":"93","author":"Bayliss","year":"1990","journal-title":"Am J Clin Pathol"},{"key":"B21","article-title":"Isolated Richter's syndrome of the brain: two recent cases","volume":"36","author":"Mah\u00e9","year":"1994","journal-title":"Nouvelle revue francaise d'hematologie"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1016\/S0248-8663(99)83011-2","article-title":"Localisation neurom\u00e9ning\u00e9e d'un syndrome de Richter","volume":"20","author":"Agard","year":"1999","journal-title":"La Revue de M\u00e9decine Interne"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1080\/10428190310001638823","article-title":"Richter's Syndrome in the Brain First Manifested as an Ischaemic Stroke","volume":"45","author":"Robak","year":"2004","journal-title":"Leuk Lymphoma"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1590\/s0004-282x2005000300031","article-title":"Isolated Richter's syndrome in central nervous system: case report","volume":"63","author":"Resende","year":"2005","journal-title":"Arquivos de neuro-psiquiatria"},{"key":"B25","article-title":"Richter transformation of chronic lymphocytic leukemia presenting as a dural-based non-hodgkin lymphoma mass","volume":"28","author":"Ghofrani","year":"2007","journal-title":"AJNR Am J Neuroradiol"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1007\/s11060-007-9334-2","article-title":"Isolated Richter's transformation of the brain","volume":"83","author":"Bagic","year":"2007","journal-title":"J Neurooncol"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1080\/07357900802189824","article-title":"Intracerebral Hodgkin's lymphoma in a patient with chronic lymphocytic leukemia\/small lymphocytic lymphoma: a case report and literature review","volume":"27","author":"Almhanna","year":"2009","journal-title":"Cancer investigation"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.3109\/10428194.2011.580480","article-title":"Richter syndrome presenting as a solitary cerebellar tumor during first-line treatment for chronic lymphocytic leukemia","volume":"52","author":"Fl\u00f8isand","year":"2011","journal-title":"Leuk Lymphoma"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1159\/000334068","article-title":"Richter syndrome and brain involvement: low-grade lymphoma relapsing as cerebral high-grade lymphoma","volume":"127","author":"Stuplich","year":"2012","journal-title":"Acta haematologica"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.3960\/jslrt.53.157","article-title":"Richter transformation in the brain from chronic lymphocytic leukemia","volume":"53","author":"Ishida","year":"2013","journal-title":"J Clin Exp Hematop: JCEH"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.3109\/10428194.2013.765565","article-title":"Central nervous system Richter's transformation and parvovirus B19 infection","volume":"54","author":"Jain","year":"2013","journal-title":"Leuk Lymphoma"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1097\/md.0000000000012701","article-title":"Richter's syndrome of the central nervous system diagnosed concurrently with chronic lymphocytic leukaemia: A case report and literature review","volume":"97","author":"Xu","year":"2018","journal-title":"Medicine"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1007\/s00277-018-3322-9","article-title":"Isolated Richter's syndrome of the brain: diagnosis in the eye of the beholder","volume":"97","author":"Pinto","year":"2018","journal-title":"Ann Hematol"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.4103\/ijc.IJC_31_19","article-title":"Isolated Richter's transformation in central nervous system in a patient with refractory chronic lymphocytic leukemia","volume":"58","author":"Cetintepe","year":"2021","journal-title":"Indian J Cancer"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1017\/cjn.2020.281","article-title":"Richter's Syndrome of the Central Nervous System","volume":"48","author":"Pronello","year":"2021","journal-title":"Can J Neurol Sci"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.3960\/jslrt.22017","article-title":"An experience with ibrutinib monotherapy for Richter's syndrome isolated in the central nervous system","volume":"62","author":"Nato","year":"2022","journal-title":"J Clin Exp Hematop: JCEH"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1007\/s00277-022-04827-6","article-title":"Richter's syndrome in central nervous system with MYD88L265P and CD79b mutation responded well to ibrutinib containing chemotherapy: a case report and review of the literature","volume":"101","author":"Wang","year":"2022","journal-title":"Ann Hematol"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1635589\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,18]],"date-time":"2025-07-18T04:10:27Z","timestamp":1752811827000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1635589\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,18]]},"references-count":37,"alternative-id":["10.3389\/fimmu.2025.1635589"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2025.1635589","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,18]]},"article-number":"1635589"}}